Metabolic reprogramming of donor T cells enhances graft-versus-leukemia effects in mice and humans

被引：84

作者：

Uhl, Franziska M. ^{[1
,2
]}

Chen, Sophia ^{[1
,3
]}

O'Sullivan, David ^{[4
]}

Edwards-Hicks, Joy ^{[4
]}

Richter, Gesa ^{[5
]}

Haring, Eileen ^{[1
,2
]}

Andrieux, Geoffroy ^{[6
,7
,8
]}

Halbach, Sebastian ^{[9
]}

Apostolova, Petya ^{[1
,4
]}

Buscher, Jorg ^{[4
]}

Duquesne, Sandra ^{[1
]}

Melchinger, Wolfgang ^{[1
]}

Sauer, Barbara ^{[1
]}

Shoumariyeh, Khalid ^{[1
]}

Schmitt-Graeff, Annette ^{[10
]}

Kreutz, Marina ^{[11
,12
]}

Lubbert, Michael ^{[1
]}

Duyster, Justus ^{[1
]}

Brummer, Tilman ^{[7
,8
,9
]}

Boerries, Melanie ^{[6
,7
,8
]}

Madl, Tobias ^{[5
,13
]}

Blazar, Bruce R. ^{[14
]}

Gross, Olaf ^{[15
,16
,17
]}

Pearce, Erika L. ^{[4
]}

Zeiser, Robert ^{[1
,16
,17
]}

机构：

[1] Univ Freiburg, Fac Med, Med Ctr, Dept Internal Med 1, D-79106 Freiburg, Germany

[2] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany

[3] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Dept Immunol, New York, NY 10065 USA

[4] Max Planck Inst Immunobiol & Epigenet, Dept Immunometab, D-79108 Freiburg, Germany

[5] Med Univ Graz, Gottfried Schatz Res Ctr Cell Signaling Metab & A, Mol Biol & Biochem, A-8010 Graz, Austria

[6] Univ Freiburg, Fac Med, Med Ctr, Inst Med Bioinformat & Syst Med, D-79110 Freiburg, Germany

[7] German Canc Consortium DKTK, Partner Site Freiburg, D-69120 Heidelberg, Germany

[8] German Canc Res Ctr, D-69120 Heidelberg, Germany

[9] Univ Freiburg, Fac Med, Inst Mol Med & Cell Res IMMZ, D-79104 Freiburg, Germany

[10] Univ Freiburg, D-79085 Freiburg, Germany

[11] Univ Hosp Regensburg, Internal Med 3, D-93042 Regensburg, Germany

[12] Regensburg Ctr Intervent Immunol RCI, D-93053 Regensburg, Germany

[13] BioTechMed Graz, A-8010 Graz, Austria

[14] Univ Minnesota, Dept Pediat, Div Blood & Marrow Transplantat, Minneapolis, MN 55455 USA

[15] Univ Freiburg, Fac Med, Med Ctr, Inst Neuropathol, D-79106 Freiburg, Germany

[16] Univ Freiburg, Signalling Res Ctr BIOSS, D-79106 Freiburg, Germany

[17] Univ Freiburg, CIBSS Ctr Integrat Biol Signalling Studies, D-79106 Freiburg, Germany

来源：

SCIENCE TRANSLATIONAL MEDICINE | 2020年 / 12卷 / 567期

基金：

欧洲研究理事会;

关键词：

ACUTE MYELOID-LEUKEMIA; HOST-DISEASE; RELAPSE; TRANSPLANTATION; SURVIVAL; INFUSIONS; THERAPY; IMPACT; PH;

D O I：

10.1126/scitranslmed.abb8969

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

Acute myeloid leukemia (AML) relapse after allogeneic hematopoietic cell transplantation (allo-HCT) has a dismal prognosis. We found that T cells of patients relapsing with AML after allo-HCT exhibited reduced glycolysis and interferon-gamma production. Functional studies in multiple mouse models of leukemia showed that leukemia-derived lactic acid (LA) interfered with T cell glycolysis and proliferation. Mechanistically, LA reduced intracellular pH in T cells, led to lower transcription of glycolysis-related enzymes, and decreased activity of essential metabolic pathways. Metabolic reprogramming by sodium bicarbonate (NaBi) reversed the LA-induced low intracellular pH, restored metabolite concentrations, led to incorporation of LA into the tricarboxylic acid cycle as an additional energy source, and enhanced graft-versus-leukemia activity of murine and human T cells. NaBi treatment of post-allo-HCT patients with relapsed AML improved metabolic fitness and interferon-y production in T cells. Overall, we show that metabolic reprogramming of donor T cells is a pharmacological strategy for patients with relapsed AML after allo-HCT.

引用

页数：14

共 50 条

[31] Generation of multi-leukemia antigen-specific T cells to enhance the graft-versus-leukemia effect after allogeneic stem cell transplant
Weber, G.
Gerdemann, U.
Caruana, I.
Savoldo, B.
Hensel, N. F.
Rabin, K. R.
Shpall, E. J.
Melenhorst, J. J.
Leen, A. M.
Barrett, A. J.
Bollard, C. M.
LEUKEMIA, 2013, 27 (07) : 1538 - 1547
[32] Lack of IL-21 signal attenuates graft-versus-leukemia effect in the absence of CD8 T-cells
Meguro, A.
Ozaki, K.
Hatanaka, K.
Oh, I.
Sudo, K.
Ohmori, T.
Matsu, H.
Tatara, R.
Sato, K.
Sakata, Y.
Nakae, S.
Leonard, W. J.
Ozawa, K.
BONE MARROW TRANSPLANTATION, 2011, 46 (12) : 1557 - 1565
[33] Clonal expansion of CD8+ T cells reflects graft-versus-leukemia activity and precedes durable remission following DLI
Schultze-Florey, Christian R.
Kuhlmann, Leonie
Raha, Solaiman
Barros-Martins, Joana
Odak, Ivan
Tan, Likai
Xiao, Yankai
Ravens, Sarina
Hambach, Lothar
Venturini, Letizia
Stadler, Michael
Eder, Matthias
Thol, Felicitas
Heuser, Michael
Foerster, Reinhold
Ganser, Arnold
Prinz, Immo
Koenecke, Christian
BLOOD ADVANCES, 2021, 5 (21) : 4485 - 4499
[34] Bendamustine with total body irradiation conditioning yields tolerant T-cells while preserving T-cell-dependent graft-versus-leukemia
Stokes, Jessica
Hoffman, Emely A.
Molina, Megan S.
Kummet, Nicole
Simpson, Richard J.
Zeng, Yi
Katsanis, Emmanuel
ONCOIMMUNOLOGY, 2020, 9 (01):
[35] Early and Sustained Expansion of Adaptive Natural Killer Cells Following Haploidentical Transplantation and CTLA4Ig-Primed Donor Lymphocyte Infusions Dissociate Graft-versus-Leukemia and Graftversus-Host Effects
Jaiswal, Sarita Rani
Chakraborty, Sushmita
Lakhchaura, Rohit
Shashi, Pooja
Mehta, Anupama
Soni, Mayank
Chakrabarti, Suparno
TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (02): : 144 - 151
[36] The role and novel use of natural killer cells in graft-versus-leukemia reactions after allogeneic transplantation
Hadjis, Ashley D.
McCurdy, Shannon R.
FRONTIERS IN IMMUNOLOGY, 2024, 15
[37] Graft-versus-leukemia effect with a WT1-specific T-cell response induced by azacitidine and donor lymphocyte infusions after allogeneic hematopoietic stem cell transplantation
Ishikawa, Tatsunori
Fujii, Nobuharu
Imada, Masahide
Aoe, Michinori
Meguri, Yusuke
Inomata, Tomoko
Nakashimai, Hiromi
Fujii, Keiko
Yoshida, Shohei
Nishimori, Hisakazu
Matsuoka, Ken-Ichi
Kondo, Eisei
Maeda, Yoshinobu
Tanimoto, Mitsune
CYTOTHERAPY, 2017, 19 (04) : 514 - 520
[38] Donor Lymphocyte Infusions for Chronic Myeloid Leukemia Relapsing after Allogeneic Stem Cell Transplantation: May We Predict Graft-versus-Leukemia Without Graft-versus-Host Disease?
Radujkovic, Aleksandar
Guglielmi, Cesare
Bergantini, Stefania
Iacobelli, Simona
van Biezen, Anja
Milojkovic, Dragana
Gratwohl, Alois
Schattenberg, Antonius V. M. B.
Verdonck, Leo F.
Niederwieser, Dietger W.
de Witte, Theo
Kroeger, Nicolaus
Olavarria, Eduardo
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (07) : 1230 - 1236
[39] The graft-versus-leukemia effect of prophylactic donor lymphocyte infusions after allogeneic stem cell transplantation is equally effective in relapse prevention but safer compared to spontaneous graft-versus-host disease
Stadler, Michael
Hambach, Lothar
Dammann, Elke
Diedrich, Helmut
Kamal, Haytham
Hamwi, Iyas
Schultze-Florey, Christian
Varvenne, Michael
Ehrlich, Steve
Buchholz, Stefanie
Koenecke, Christian
Beutel, Gernot
Weissinger, Eva M.
Krauter, Juergen
Eder, Matthias
Hertenstein, Bernd
Ganser, Arnold
ANNALS OF HEMATOLOGY, 2023, 102 (09) : 2529 - 2542
[40] Immunosuppression for 6-8 weeks after modified donor lymphocyte infusion reduced acute graft-versus-host disease without influencing graft-versus-leukemia effect in haploidentical transplant
Yan Chenhua
Xu Lanping
Liu Daihong
Chen Huan
Wang Yu
Liu Kaiyan
Huang Xiaojun
CHINESE MEDICAL JOURNAL, 2014, 127 (20) : 3602 - 3609

← 1 2 3 4 5 →